(Q52052815)

20 April 2018

title

HIV-specific lymphoproliferative responses in asymptomatic HIV-infected individuals. (English)

1 reference

20 April 2018

author name string

Pontesilli O

1

1 reference

20 April 2018

Carlesimo M

2

1 reference

20 April 2018

Varani AR

3

1 reference

20 April 2018

Ferrara R

4

1 reference

20 April 2018

Guerra EC

5

1 reference

20 April 2018

Bernardi ML

6

1 reference

20 April 2018

Ricci G

7

1 reference

20 April 2018

Mazzone AM

8

1 reference

20 April 2018

D'Offizi G

9

1 reference

20 April 2018

Aiuti F

10

1 reference

20 April 2018

publication date

1 June 1995

1 reference

20 April 2018

Clinical and Experimental Immunology

published in

1 reference

20 April 2018

volume

100

1 reference

20 April 2018

issue

3

1 reference

20 April 2018

page(s)

419-424

1 reference

20 April 2018

A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB03716.X

Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB03716.X

Cell-mediated immunity to recombinant human immunodeficiency virus (HIV) antigens in HIV-infected populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB03716.X

Exposure to human immunodeficiency virus (HIV) type I indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB03716.X

Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB03716.X

Kinetics and specificities of the T helper-cell response to gp120 in the asymptomatic stage of HIV-1 infection

21 January 2018

1 reference

12 December 2020

HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood

1 reference

12 December 2020

Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro

1 reference

12 December 2020

Mucosal cell-mediated immunity to varicella zoster virus: role in protection against disease

1 reference

12 December 2020

Impaired specific cellular response to HTLV-III before other immune defects in patients with HTLV-III infection.

1 reference

12 December 2020

Epitopes of the CD4 antigen and HIV infection

1 reference

12 December 2020

Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection

1 reference

12 December 2020

T cell recognition of HIV synthetic peptides in a natural infection

1 reference

12 December 2020

Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro

1 reference

12 December 2020

Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals

1 reference

12 December 2020

Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging

1 reference

12 December 2020

HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4

1 reference

12 December 2020

Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men.

1 reference

12 December 2020

Lymphoproliferative responses to mitogens and HIV-1 envelope glycoprotein among volunteers vaccinated with recombinant gp160

1 reference

12 December 2020

Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens

1 reference

12 December 2020

The immunopathogenesis of human immunodeficiency virus infection

1 reference

12 December 2020

Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.

1 reference

12 December 2020

In vitro lymphocyte proliferative response to HIV-1 p24 is associated with a lack of CD4+ cell decline

1 reference

12 December 2020

10.1111/J.1365-2249.1995.TB03716.X

Identifiers

DOI

1 reference

20 April 2018

0 references

1 reference

20 April 2018